TG Therapeutics (TGTX) Nukunuku Sɛn
Prévision IA: TGTX
AI ɖo nɔvɔxɔsisa ɖo xɔsin ɖo gbe ɖagbe, xɔsin ɖo xwe ɖagbe, kpodo xɔsin ɖo xwe ɖagbe kpo. Xɔsin ɖo xɔsin ɖo xɔsin ɖo xɔsin. Xɔsin ɖo xɔsin ɖo xɔsin, ɖo xɔsin ɖo xɔsin.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA pour 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Déverrouiller Premium🔒 Nukunukunukunukunuku
The forecast track record — every past forecast next to the actual close — is part of Premium.
Déverrouiller PremiumGɔn Kɛntɔn E Nɔví
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.